EMPLOYMENT AGREEMENTEmployment Agreement • July 26th, 2024 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Contract Type FiledJuly 26th, 2024 Company IndustryThis Employment Agreement (“Agreement”) is made between HOOKIPA Biotech GmbH (the “Company”), and Dr. Malte Peters (the “Executive”) and is made effective with July 22, 2024 and is concluded for an indefinite period (“Term”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2024 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Contract Type FiledMay 9th, 2024 Company IndustryThis Employment Agreement (“Agreement”) is made between HOOKIPA Biotech GmbH (the “Company”), and Mark Winderlich (the “Executive”) and is made effective as of June 1, 2024 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 24th, 2022 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Contract Type FiledMarch 24th, 2022 Company IndustryThis Employment Agreement (“Agreement”) is made between HOOKIPA Biotech GmbH (the “Company”), and Klaus Orlinger (the “Executive”) and is made effective as of January 1, 2022 (the “Effective Date”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • April 8th, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Contract Type FiledApril 8th, 2019 Company IndustryThis Amended and Restated Employment Agreement (“Agreement”) is made between HOOKIPA Biotech GmbH (the “Company”), and Joern Aldag (the “Executive”) and is made effective as of the closing of the first underwritten public offering of the equity securities of HOOKIPA Pharma Inc. (“Parent”) pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • April 8th, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Contract Type FiledApril 8th, 2019 Company IndustryThis Amended and Restated Employment Agreement (“Agreement”) is made between HOOKIPA Biotech GmbH (the “Company”), and Reinhard Kandera (the “Executive”) and is made effective as of the closing of the first underwritten public offering of the equity securities of HOOKIPA Pharma Inc. (“Parent”) pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”).